MYX.AX
Price:
$4.56
Market Cap:
$370.48M
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name t...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2007-06-29
Stock Exchange
ASX
Ticker
MYX.AX
According to Mayne Pharma Group Limited’s latest financial reports and current stock price. The company's current ROE is -34.78%. This represents a change of 71.94% compared to the average of -20.23% of the last 4 quarters.
The mean historical ROE of Mayne Pharma Group Limited over the last ten years is -19.49%. The current -34.78% ROE has changed 78.42% with respect to the historical average. Over the past ten years (40 quarters), MYX.AX's ROE was at its highest in in the June 2014 quarter at 8.07%. The ROE was at its lowest in in the June 2022 quarter at -37.71%.
Average
-19.49%
Median
-19.03%
Minimum
-51.53%
Maximum
10.27%
Discovering the peaks and valleys of Mayne Pharma Group Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 311.45%
Maximum Annual ROE = 10.27%
Minimum Annual Increase = -260.82%
Minimum Annual ROE = -51.53%
Year | ROE | Change |
---|---|---|
2024 | -38.36% | -23.09% |
2023 | -49.88% | -3.20% |
2022 | -51.53% | 89.96% |
2021 | -27.13% | 203.31% |
2020 | -8.94% | -67.74% |
2019 | -27.72% | 153.76% |
2018 | -10.92% | -260.82% |
2017 | 6.79% | -33.85% |
2016 | 10.27% | 311.45% |
2015 | 2.50% | -81.33% |
The current ROE of Mayne Pharma Group Limited (MYX.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-46.59%
5-year avg
-35.17%
10-year avg
-19.49%
Mayne Pharma Group Limited’s ROE is less than Nanosonics Limited (7.25%), greater than Estia Health Limited (-6.50%), less than G8 Education Limited (6.76%), less than Blackmores Limited (7.96%), greater than Mesoblast Limited (-17.79%),
Company | ROE | Market cap |
---|---|---|
7.25% | $944.03M | |
-6.50% | $547.74M | |
6.76% | $1.03B | |
7.96% | $1.84B | |
-17.79% | $3.22B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mayne Pharma Group Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mayne Pharma Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Mayne Pharma Group Limited's ROE?
How is the ROE calculated for Mayne Pharma Group Limited (MYX.AX)?
What is the highest ROE for Mayne Pharma Group Limited (MYX.AX)?
What is the 3-year average ROE for Mayne Pharma Group Limited (MYX.AX)?
What is the 5-year average ROE for Mayne Pharma Group Limited (MYX.AX)?
How does the current ROE for Mayne Pharma Group Limited (MYX.AX) compare to its historical average?